EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes(137 views)(PDF restricted49 views) Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen NI, Brooks DJ, Darcourt J, Dickson JC, Douglas D, Drzezga A, Dubroff J, Ekmekcioglu O, Garibotto V, Herscovitch P, Kuo P, Lammertsma A, Pappata S
Paper type: Journal Article, Research Support, N. I. H. , Extramural
, Non-U. S. Gov'T
, Non-P. H. S.,
Impact factor: 7.18, 5-year impact factor: 4.665
Url: Not available.
Keywords: Brain
, Dat
, Dopa
, Pet
, Parkinson
, Parkinsonian Syndromes
, Spect,
Affiliations: *** IBB - CNR ***
IRCCS Ospedale Policlinico San Martino, Genoa, Italy
grid.411663.70000 0000 8937 0972Nuclear Medicine, Department of Radiology, Medstar Georgetown University Hospital, 3800 Reservoir Road NW CCC Bldg, Washington, DC 20007 USA
Department of Nuclear Medicine, University of Navarra, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
grid.9647.c0000 0004 7669 9786Department of Nuclear Medicine, Leipzig University, Leipzig, Germany
grid.12380.380000 0004 1754 9227Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, NeuroScience, De Boelelaan 1117, Amsterdam, The Netherlands
grid.214458.e0000000086837370Departments Radiology & Neurology, University of Michigan & Ann Arbor Veterans Medical Center, Ann Arbor, MI USA
grid.7048.b0000 0001 1956 2722Department of Nuclear Medicine, Aarhus University, Aarhus, Denmark
grid.460782.f0000 0004 4910 6551Nuclear Medicine, Department of imaging, Centre Antoine Lacassagne, Université Cote d’Azur, Nice, France
grid.52996.310000 0000 8937 2257Institute of Nuclear Medicine, University College London Hospitals NHS Foundation Trust, London, UK
grid.168010.e0000000419368956Department of Nuclear Medicine and Neuroradiology, Stanford University, Stanford, CA USA
grid.6190.e0000 0000 8580 3777Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
grid.25879.310000 0004 1936 8972Division of Nuclear Medicine and Clinical Molecular Imaging in the Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA USA
grid.416011.30000 0004 0642 8884Department of Nuclear Medicine, Sisli Etfal Education and Research Hospital, Istanbul, Turkey
grid.8591.50000 0001 2322 4988NIMTLab, Faculty of Medicine, Geneva University, Geneva, Switzerland
grid.94365.3d0000 0001 2297 5165Positron Emission Tomography Department, NIH/CC, Bethesda, MD USA
grid.134563.60000 0001 2168 186XDepartments of Medica
References: Not available.
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes
PURPOSE: This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The goal of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of dopaminergic imaging in parkinsonian syndromes. METHODS: Currently nuclear medicine investigations can assess both presynaptic and postsynaptic function of dopaminergic synapses. To date both EANM and SNMMI have published procedural guidelines for dopamine transporter imaging with single photon emission computed tomography (SPECT) (in 2009 and 2011, respectively). An EANM guideline for D2 SPECT imaging is also available (2009). Since the publication of these previous guidelines, new lines of evidence have been made available on semiquantification, harmonization, comparison with normal datasets, and longitudinal analyses of dopamine transporter imaging with SPECT. Similarly, details on acquisition protocols and simplified quantification methods are now available for dopamine transporter imaging with PET, including recently developed fluorinated tracers. Finally, [(18)F]fluorodopa PET is now used in some centers for the differential diagnosis of parkinsonism, although procedural guidelines aiming to define standard procedures for [(18)F]fluorodopa imaging in this setting are still lacking. CONCLUSION: All these emerging issues are addressed in the present procedural guidelines for dopaminergic imaging in parkinsonian syndromes.
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes
No results.
EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes